Changes to the Prohibited List for 2021
The World Anti-Doping Agency (WADA) has recently released the 2021 List of Prohibited Substances and Methods, which are banned from use within sport. The new Prohibited List will come into effect on 1 January 2021. This gives athletes and their support personnel sufficient time to make themselves aware of the changes, review any medications they use, and apply for a Therapeutic Use Exemption (TUE) if required before the updated List comes into effect at the beginning of the new year.
DFSNZ Chief Executive Nick Paterson said: “Athletes and support personnel aren’t expected to remember everything on the Prohibited List, but they are expected to check all medications before taking them.
“The 2021 World Anti-Doping Code will come into effect on 1 January 2021, so please take the time to check the List before then. Our medication check feature on the DFSNZ website will be updated with the changes by 1 January 2021”
Major Changes and Clarifications
Redesign of the list: The List has been redesigned to improve navigation and usability, with the addition of a table of contents and index.
Substances of abuse: Cocaine, Diamorphine (heroin), methylenedioxymethamphetamine (MDMA/ecstasy) and tetrahydrocannabinol (THC) have been identified as substances frequently abused in society outside of the context of sport. This means that if an athlete can demonstrate that the use of any of these four substances was out of competition and unrelated to sport performance, the suspension imposed will be three months, and may be further reduced if the athlete completes a drug rehabilitation program.
S3. Beta-2 Agonists: Vilanterol has been changed from a prohibited substance to a threshold substance, meaning that it’s now permitted when a maximum of 25 micrograms is inhaled over a 24-hour period. Inhaled use exceeding this dosage remains prohibited.
Glucocorticoids: All injectable routes of administration of glucocorticoids in-competition will be prohibited in 2022. This delay is to allow time to communicate the change and develop educational tools, and for medical and support personnel to address the safe use of glucocorticoids for clinical purposes.
For further information of the full list please consult the WADA 2021 Prohibited List and the WADA 2021 Summary of Major Modifications and Explanatory Notes.